Search

Halozyme Therapeutics Inc

Gesloten

SectorGezondheidszorg

78.52 -2.23

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

78.07

Max

81.78

Belangrijke statistieken

By Trading Economics

Inkomsten

292M

150M

Verkoop

-75M

377M

K/W

Sectorgemiddelde

28.344

60.549

EPS

1.221

Winstmarge

39.832

Werknemers

423

EBITDA

-62M

220M

Aanbevelingen

By TipRanks

Aanbevelingen

Buy

12 Maanden Prognose

+0.78% upside

Dividenden

By Acuity

Volgende Winsten

4 aug 2026

Marktinformatie

By TradingEconomics

Marktkapitalisatie

1.9B

9.6B

Vorige openingsprijs

80.75

Vorige sluitingsprijs

78.52

Nieuwssentiment

By Acuity

14%

86%

21 / 342 Rangschikking in Healthcare

Halozyme Therapeutics Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

8 jul 2026, 23:51 UTC

News

Broadcom shares rise in after-market hours as analysts project $172 billion in revenue next year, driven by AI infrastructure spending.

8 jul 2026, 23:51 UTC

News
Social Media

Costco Wholesale reported net sales of $29.24 billion for June but shares declined in after-hours trading amid mixed investor sentiment and broader market trends.

8 jul 2026, 23:46 UTC

News
ETF Constituents
Macro News
Correlated Moves

The Financial Select Sector SPDR Fund is higher in after-market trading, supported by strong seasonal patterns and movements in major bank holdings.

8 jul 2026, 23:41 UTC

News
Social Media
Correlated Moves

Advanced Micro Devices shares are declining in after-hours trading amid negative sentiment in semiconductor stocks, following the announcement of its upcoming earnings report.

8 jul 2026, 23:41 UTC

Social Media
News

NVIDIA Corp shares declined in after-market trading amid concerns over AI spending and competition. Analysts note cautious investor sentiment contributing to the bearish outlook.

8 jul 2026, 23:41 UTC

News
Social Media
Correlated Moves

Micron Technology shares traded higher after notable options activity, with $7.2 million in orders for $815 7/17 Puts contributing to a total premium of over $21.5 million.

8 jul 2026, 23:36 UTC

News

PayPal Holdings Inc. shares fell in after-market trading amid geopolitical tensions and investor risk aversion following President Trump's announcement on the Iran ceasefire.

8 jul 2026, 23:26 UTC

News

Lam Research Corporation will hold a financial conference call on July 29, 2026, to discuss June quarter results. Shares are higher in after-market trading.

8 jul 2026, 23:11 UTC

Correlated Moves
Macro News
ETF Constituents
News

The Consumer Discretionary Select Sector SPDR Fund is higher in after-market trading, bolstered by Levi Strauss & Co.'s strong Q2 results and summer performance trends.

8 jul 2026, 23:06 UTC

News

United Airlines shares traded lower in after-market hours following a judge's ruling to allow a class-action lawsuit over misleading "window seat" charges.

8 jul 2026, 23:06 UTC

News

Monster Beverage Corp announced a 2-for-1 stock split, effective August 10, 2026. Shares are trading higher in after-market hours following the news.

8 jul 2026, 23:06 UTC

Correlated Moves
News
Social Media
ETF Constituents

SPDR Dow Jones Industrial Average ETF Trust is lower in after-market hours, reflecting declines in key contributors amid rising inflation concerns from escalating Middle East tensions.

8 jul 2026, 23:01 UTC

News

Geopolitical tensions following U.S. strikes in Iran have boosted United States Oil Fund LP in after-market trading, reflecting strong upward momentum since Wednesday's close.

8 jul 2026, 20:13 UTC

ETF Constituents
Correlated Moves
News

The Vanguard Large-Cap ETF is lower in after-hours trading, reflecting broader market declines amid rising crude oil prices and escalating tensions in the Middle East.

8 jul 2026, 20:07 UTC

News
Correlated Moves

Bitcoin is trading lower amid heightened geopolitical tensions and rising inflation concerns. Earlier in the session, Bitcoin briefly declined significantly before recovering slightly.

8 jul 2026, 20:07 UTC

News
Correlated Moves

Geopolitical tensions following President Trump's U.S.-Iran ceasefire announcement support a modest rise in CAD/HKD during Wednesday's session. The pair is up since Tuesday's close.

8 jul 2026, 20:07 UTC

News
Correlated Moves

Bitcoin is trading lower amid heightened geopolitical tensions following President Trump's declaration on Iran. The asset remains under pressure from rising inflation concerns.

8 jul 2026, 20:06 UTC

Social Media
Macro Event
News

Cisco Systems Inc shares are higher today following the US Wholesale Inventories report, which showed a smaller-than-expected increase for May. Concerns about a price breakdown persist.

8 jul 2026, 20:04 UTC

News

J B Hunt Transport shares rise as Stephens initiates Overweight rating and TD Cowen raises price target to $265 ahead of earnings report.

8 jul 2026, 20:04 UTC

Correlated Moves
Social Media
News

Intuit Inc. shares are lower amid an investigation into potential securities fraud by Bleichmar Fonti & Auld LLP related to pricing issues ahead of tax season.

8 jul 2026, 20:04 UTC

Social Media
News
Correlated Moves

Amazon shares are lower as TD Cowen lowers its price target to $340 ahead of earnings, amid concerns over significant investments and high borrowing.

8 jul 2026, 20:04 UTC

News
Social Media
Correlated Moves

Alphabet Inc shares are lower despite confirmation of a major presence at the Calgary Stampede, reflecting broader market trends amid global tensions.

8 jul 2026, 20:04 UTC

News
Correlated Moves

Alphabet Inc shares are lower, affected by declines in the Interactive Media & Services sub-sector and a drop in the S&P 500 Index.

8 jul 2026, 20:04 UTC

Social Media
News
Correlated Moves

Meta Platforms Inc. shares are lower as France's competition authority mandates renewed negotiations with local media over unpaid publishing fees, amid broader market declines.

8 jul 2026, 20:04 UTC

Social Media
News
Correlated Moves

Qualcomm Inc is rising amid strong gains in the Semiconductors sector. Social media discussions note key resistance levels around $185.13 and $186.32.

8 jul 2026, 20:03 UTC

ETF Constituents
News
Correlated Moves

Vanguard Small-Cap ETF is lower as Goldman Sachs warns of waning favorable conditions for small-cap stocks amid rising interest burdens and declining holdings.

8 jul 2026, 20:03 UTC

Macro News
News
ETF Constituents
Correlated Moves

The Industrial Select Sector SPDR Fund is trading lower as rising oil prices and inflation concerns pressure the sector amid geopolitical tensions.

8 jul 2026, 20:02 UTC

News

Expedia Group Inc shares declined as geopolitical tensions rose after President Trump's Iran ceasefire remarks, raising concerns about travel demand and costs.

8 jul 2026, 20:02 UTC

News

NXP Semiconductors NV is trading higher, supported by Cantor Fitzgerald's endorsement and positive outlook for its automotive segment growth through 2027.

8 jul 2026, 19:57 UTC

Social Media
News

Tesla Inc. shares are lower today amid operational pressures and competitive developments, including scrutiny over Full Self-Driving and new competition in robotics.

Peer Vergelijking

Prijswijziging

Halozyme Therapeutics Inc Prognose

Koersdoel

By TipRanks

0.78% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 81 USD  0.78%

Hoogste 96 USD

Laagste 57 USD

Gebaseerd op 6 Wall Street-analisten die 12-maands prijsdoelen bieden voor Halozyme Therapeutics Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

6 ratings

3

Buy

2

Hold

1

Sell

Sentiment

By Acuity

21 / 342 Rangschikking in Gezondheidszorg

Nieuwssentiment

Zeer Sterk Bearish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Boven gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Halozyme Therapeutics Inc

Halozyme Therapeutics, Inc., a biopharma technology platform company, researches, develops, and commercializes proprietary enzymes and devices in the United States, Switzerland, Belgium, Japan, and internationally. The company's products are based on the patented recombinant human hyaluronidase enzyme (rHuPH20) that enables delivery of injectable biologics, such as monoclonal antibodies and other therapeutic molecules, as well as small molecules and fluids. It offers Hylenex recombinant, a formulation of rHuPH20 to facilitate subcutaneous (SC) fluid administration for achieving hydration to enhance the dispersion and absorption of other injected drugs in SC urography and to enhance resorption of radiopaque agents; rilpivirine, cabotegravir, and N6LS BNAB for the treatment of HIV; ocrelizumab for multiple sclerosis; XYOSTED, an injection for SC administration of testosterone replacement therapy; and ATRS-1902, a proprietary drug device combination product. The company also provides Herceptin (trastuzumab), Herceptin Hylecta, and Phesgo to treat breast cancer; Mabthera SC for the treatment of chronic lymphocytic leukemia; HYQVIA to treat primary immunodeficiency disorders; and DARZALEX for patients with amyloidosis, smoldering myeloma, and multiple myeloma. In addition, it offers Epinephrine Injection to treat allergic reactions; nivolumab+relatlimab and ANTI-TIM3 for the treatment of solid tumors; ARGX-117 for multifocal motor neuropathy; atezolizumab; nivolumab; afgartigimod; teriparatide injections; and OTREXUP, a SC methotrexate injection for adults with severe active rheumatoid arthritis and severe recalcitrant psoriasis, as well as children with active polyarticular juvenile idiopathic arthritis. Further, the company provides ATRS-1902 for adrenal crisis rescue; ARGX-113; and ARGX-117 to treat severe autoimmune diseases in multifocal motor neuropathy. Halozyme Therapeutics, Inc. was founded in 1998 and is headquartered in San Diego, California.
help-icon Live chat